Role of sodium fluorescein in pediatric low-grade glioma surgery: an update

被引:0
|
作者
de Laurentis, Camilla [1 ,2 ]
Pasquali, Claudia [1 ]
Beuriat, Pierre-Aurelien [1 ,2 ,3 ]
Mottolese, Carmine [1 ]
Szathmari, Alexandru [1 ,2 ]
Vinchon, Matthieu [1 ]
Di Rocco, Federico [1 ,3 ]
机构
[1] Hop Femme Mere Enfant, Pediat Neurosurg Unit, Lyon, France
[2] Hop Pierre Wertheimer, Funct Neurosurg Unit, Lyon, France
[3] Univ Claude Bernard Lyon 1, Dept Med & Surg, Lyon, France
关键词
Pilocytic astrocytoma; Low-grade glioneuronal tumors; YELLOW 560 nm filter; Fluorophore; Pediatric neuro-oncology; SURGICAL MICROSCOPE; BRAIN-TUMORS; RESECTION; INJECTION; CHILDREN;
D O I
10.1007/s00381-024-06402-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PurposeComplete surgical resection is still the mainstay in the treatment of central nervous system low-grade tumors, eventually resulting curative. The complete surgical removal of these lesions, however, may be difficult in some cases because of their infiltrative nature. Intraoperative adjuncts may be a game changer. Sodium fluorescein (SF) is among the ideal candidates as intraoperative tools to favor the actual recognition of the tumor extension, since it accumulates in areas of altered blood-brain barrier, a typical characteristic of pediatric gliomas, and has a low rate of adverse events. This work proposes an update of previous works about the evaluation of the feasibility and usefulness of a systematic use of SF in a low-grade lesion group of pediatric patients.MethodsPediatric patients operated on for a resection or a biopsy of a low-grade glial or glioneuronal lesion (WHO grade I and II) at our Institution between September 2021 and December 2023, with the intraoperative use of sodium fluorescein (SF), were enrolled in the study. We collected pre-operative and postoperative clinical and radiological data, intraoperative findings, and post-operative pathological diagnoses.ResultsNo adverse events were registered related to the intraoperative use of SF. SF appeared useful for the localization of boundaries of tumors, especially when characterized by a high degree of infiltration or by a deep-seated location, and for the checking of possible tumor remnants at the end of surgery. A good tumor-to-healthy tissue contrast was registered when tumor visualization was in a range between 1 to 2 h and 30 min after SF injection. Possible "false positives" due to intraoperative vascular wall injury and clearance of SF from both tumor and healthy tissue were observed in some cases and still remain open issues.ConclusionsSF is a feasible and safe intraoperative adjunct tool in the surgical removal of pediatric low-grade tumors. SF may show its usefulness especially in selected cases, such as deep-seated lesions and infiltrating tumors. Its safety profile, user-friendly management, and potential utility in both tumor resections and neuronavigated biopsies favor its wider use in the surgical treatment of pediatric low-grade tumors.
引用
收藏
页码:3143 / 3154
页数:12
相关论文
共 50 条
  • [1] Pediatric Low-Grade Glioma Surgery with Sodium Fluorescein: Efficient Localization for Removal and Association with Intraoperative Pathological Sampling
    de Laurentis, Camilla
    Beuriat, Pierre Aurelien
    Bteich, Fred
    Mottolese, Carmine
    Szathmari, Alexandru
    Vinchon, Matthieu
    Di Rocco, Federico
    DIAGNOSTICS, 2022, 12 (12)
  • [2] How modern treatments have modified the role of surgery in pediatric low-grade glioma
    Boop, Scott
    Shimony, Nir
    Boop, Frederick
    CHILDS NERVOUS SYSTEM, 2024, 40 (10) : 3357 - 3365
  • [3] The "Risk'' in Pediatric Low-Grade Glioma
    Fangusaro, Jason
    Bandopadhayay, Pratiti
    CANCER CELL, 2020, 37 (04) : 424 - 425
  • [4] Management of pediatric low-grade glioma
    de Blank, Peter
    Bandopadhayay, Pratiti
    Haas-Kogan, Daphne
    Fouladi, Maryam
    Fangusaro, Jason
    CURRENT OPINION IN PEDIATRICS, 2019, 31 (01) : 21 - 27
  • [5] Radiotherapy for pediatric low-grade glioma
    Bansal, Indu
    Merchant, Thomas E.
    CHILDS NERVOUS SYSTEM, 2024, : 3277 - 3290
  • [6] Temozolomide in pediatric low-grade glioma
    Khaw, Seong L.
    Coleman, Lee T.
    Downie, Peter A.
    Heath, John A.
    Ashley, David M.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (06) : 808 - 811
  • [7] Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma
    Bitterman, Danielle S.
    MacDonald, Shannon M.
    Yock, Torunn I.
    Tarbell, Nancy J.
    Wright, Karen D.
    Chi, Susan N.
    Marcus, Karen J.
    Haas-Kogan, Daphne A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (35) : 3335 - +
  • [8] Role of surgery in the treatment of pediatric low-grade glioma with various degrees of brain stem involvement
    Lorincz, Katalin Nora
    Gorodezki, David
    Schittenhelm, Jens
    Zipfel, Julian
    Tellermann, Jonas
    Tatagiba, Marcos
    Ebinger, Martin
    Schuhmann, Martin Ulrich
    CHILDS NERVOUS SYSTEM, 2024, : 3037 - 3050
  • [9] Second-look surgery in postoperative pediatric low-grade glioma
    Rufus, Phelix
    Chatterjee, Sandip
    CHILDS NERVOUS SYSTEM, 2024, : 3135 - 3142
  • [10] Phase II study of temozolomide in pediatric low-grade glioma: An update report
    Cappellano, A. M.
    Rogerio, J.
    Pereira, L. M. S.
    Galvao, C.
    Pascoalichio, A. P.
    Cavalheiro, S.
    Dastoli, P. A.
    Silva, N. S.
    NEURO-ONCOLOGY, 2007, 9 (02) : 189 - 190